Arrhythmias & electrophysiology

Current management of atrial fibrillation in routine practice according to the last ESC guidelines: an European Heart Rhythm Association (EHRA) physician survey—how are we dealing with controversial approaches?

EuropacePublished Cross-sectional study

Authors' conclusion

There is marked heterogeneity in AF management and limited accordance to last guidelines in the EHRA community.

Study context

Population
Physicians of the EHRA community (EHRA Research Network, National Societies, social media), January–February 202361% from university hospitals
Participants
181 physicians
Outcome
Current clinical practice in AF management according to last ESC guidelines
Methodological detailsphysician survey, 30 multiple-choice questionnaire
  • Physician survey
  • 30 multiple-choice questionnaire

Main finding

As reported in the abstract

Atrial fibrillation (AF) screening regularly performed in high-risk patients
57%
Access to ≥1 programme for diagnosing/managing comorbidities and lifestyle modifications (marked heterogeneity between countries)
42%
DOACs preferred antithrombotic
97%
Rhythm control preferred: symptomatic vs asymptomatic paroxysmal AF
97% vs. 77%
Rhythm control preferred: low vs high recurrence risk persistent AF
90% vs. 72%
Rhythm control preferred: permanent AF
20%
Ablation first-line for symptomatic paroxysmal AF
69%
Ablation first-line for persistent AF with markers of atrial disease
57%
Ablation performed independently of symptoms
15%
Persistent AF: pulmonary vein isolation only
68%
Persistent AF: additional lesions
32%

Observational data: associations, not effects.

Original publication

Current management of atrial fibrillation in routine practice according to the last ESC guidelines: an EHRA physician survey—how are we dealing with controversial approaches? Europace. Published 16 January 2024. doi:10.1093/europace/euae012

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.